Socioeconomic considerations in erectile dysfunction treatment.
The socioeconomics of  erectile dysfunction have been changed greatly by the introduction of the successful oral therapy, sildenafil. The population of patients presenting for treatment of erectile dysfunction has expanded significantly and rapidly. This article addresses the descriptive and analytic economic implications of erectile dysfunction treatment.
Shabsigh
R
R
Department of Urology, Columbia University, New York, New York, USA. RS66@columbia.edu
D017281:Cost of Illness; D016527:Drug Costs; D007172:Erectile Dysfunction / Q000191:economics* / Q000628:therapy; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000191:economics / Q000627:therapeutic use; D011687:Purines; D011788:Quality of Life; D000068677:Sildenafil Citrate; D012959:Socioeconomic Factors; D013450:Sulfones; D014481:United States
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate